BARCLAY A PHILLIPS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BARCLAY A PHILLIPS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BARCLAY A PHILLIPS. BARCLAY A PHILLIPS is a SVP, Chief Financial Officer in NOVAVAX INC ($NVAX) and a Director in MICROMET, INC. ($MITI) and a Director in IMMUNIC, INC. ($VTL) and a SVP & Chief Financial Officer in G1 Therapeutics, Inc. ($GTHX).
Address: 2110 RUTHERFORD RD. CARLSBAD 92008 CA
Companies in which BARCLAY A PHILLIPS is an Insider
G1 Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BARCLAY A PHILLIPS: SVP & Chief Financial Officer
Holdings: 5,000 shares
Latest Transaction: Jan 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BARCLAY A PHILLIPS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 06 2020
$VTL Market Capitalization: $153.84M
$VTL Previous Close: $4.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MICROMET, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BARCLAY A PHILLIPS: Director
Holdings: 0 shares
Latest Transaction: Jun 16 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVAVAX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BARCLAY A PHILLIPS: SVP, Chief Financial Officer
Holdings: 38,669 shares
Current Value: $50,656
Latest Transaction: Aug 01 2017
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of BARCLAY A PHILLIPS
Sentiment: All, GTHX, VTL, MITI, NVAX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2020 | VTL | IMMUNIC, INC. | PHILLIPS BARCLAY A | Director | Option Exercise | A | 12.30 | 15,000 | 184,500 | 15,000 | |
| Nov 19 2019 | VTL | IMMUNIC, INC. | PHILLIPS BARCLAY A | Director | Option Exercise | A | 7.63 | 29,959 | 228,587 | 29,959 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Option Exercise | A | 19.56 | 60,000 | 1,173,600 | 60,000 | |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Option Exercise | M | 19.46 | 5,000 | 97,300 | 95,000 | |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Sell | S | 39.92 | 5,000 | 199,591 | 0 | 5 K to 0 (-100.00 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Buy | M | 19.46 | 5,000 | 97,300 | 5,000 | 0 to 5 K |
| Dec 06 2017 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Option Exercise | A | 19.46 | 250,000 | 4,865,000 | 250,000 |